HFA Icon

Arquitos Capital Management Up 24% YTD: Updates On Liquidia Investment

HFA Padded
HFA Staff
Published on
Updated on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

Arquitos Capital Management commentary for the second quarter ended June 30, 2024.

Dear Partner:

Arquitos returned 3.5% net of fees in the second quarter of 2024, bringing the year-to-date return to 23.5%.

We were up nearly 40% on the year at the end of May, but had a down June due to the continued delays with Liquidia coming to market with their PAH and PH-ILD inhaler, Yutrepia. I continue to be optimistic that we will get a resolution in the near term. However, we did get good news during the quarter as the judge in one of...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Premium Members Get EVEN MORE VALUE

Subscribe to Hedge Fund Alpha

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe and get an extra 20% off annual with code LETTERS
HFA Padded

The post above is drafted by the collaboration of the Hedge Fund Alpha Team.